|
GeneEd develops new Therapeutic Area e-learning curricula for the Pharmaceutical Industry covering Infectious Disease, the Musculoskeletal System, and the Kidney
San Francisco, CA, October 30, 2002—
GeneEd, Inc., the leading provider of advanced e-learning solutions for the life science industry, today announced that it has released 25 new courses in three therapeutic areas that are relevant to the Life Science and Healthcare industries: Infectious Disease, the Musculoskeletal System, and the Kidney. The comprehensive GeneEd Therapeutic Area curricula released today, in addition to the 52 courses released last month, represent significant areas of focus for research, product development, and sales in major global pharmaceutical organizations. It is critical that pharmaceutical employees have a broad understanding of the scientific and medical issues within the therapeutic areas in which they work, whether they are clinical research associates attempting to accelerate a drug through the drug development pipeline or pharmaceutical sales forces discussing science with physicians and clinicians in the field. The therapeutic areas that GeneEd has addressed represent some of the most critical subject areas that pharmaceutical employees need to be educated on.
The new GeneEd Therapeutic
Area curricula include:
Infectious Disease: Bacteria, Bacterial Infection, Antibiotics, and Sepsis.
Musculoskeletal System: Anatomy & Physiology, Musculoskeletal Pain, Rheumatoid Arthritis, and Osteoarthritis.
The Kidney: Renal Anatomy & Physiology.
"The Infectious Disease, Musculoskeletal System, and Kidney curricula bring us another step closer to developing the most comprehensive scientific and therapeutic area e-learning catalog ever assembled," said Salil Patel, Chief Scientific Officer for GeneEd. "These new Life Science e-learning courses equip pharmaceutical employees with the scientific knowledge critical to the improvement of job performance, thereby contributing to the health of the pharma organization as a whole. GeneEd is actively responding to the ever-changing training needs of the life science industry, and the introduction of these new therapeutic area courses reiterates the strength of our science and industry knowledge."
All GeneEd catalog and custom courseware are Continuing Medical Education (CME) Category One accredited and approved. The GeneEd Therapeutic Area E-Learning curricula has also been developed to allow simple technical integration of the courses into a pharmaceutical organization's Learning Management System (LMS), and all GeneEd E-Learning courses are SCORM 1.2 compliant, and have been successfully integrated with 21CFR11-compliant LMS applications.
About GeneEd
GeneEd, Inc. was founded in 1997 to provide life science and healthcare e-learning solutions for the pharmaceutical, biotechnology, instrument and medical device, and hospital/HMO industries. GeneEd's Life Science industry customers include AstraZeneca, Pfizer, the ALZA division of Johnson & Johnson, Celera, Bio-Rad, and IBM Life Sciences, amongst many others. (http://www.geneed.com/clients/index.html)
GeneEd utilizes the best life science content, combined with advanced e-learning development technology, to rapidly create basic and advanced curricula in the areas of genomics, therapeutic area training (for clinical research, product development, and sales and marketing teams), computer assisted drug design, drug discovery and development, pharmacogenomics and clinical genomics, bioinformatics and microarray informatics, and therapeutic and diagnostic products. GeneEd, Inc. is a privately held company headquartered in San Francisco, California. Visit http://www.GeneEd.com for additional information about GeneEd and its courseware.
|
